Total Payments
$12,157
2024 Payments
$3,659
Companies
61
Transactions
656
Medicare Patients
2,574
Medicare Billing
$247,892
Payment Breakdown by Category
Food & Beverage$12,036 (99.0%)
Education$102.00 (0.8%)
Other$19.18 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,036 | 651 | 99.0% |
| Education | $102.00 | 4 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19.18 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,618 | 128 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $902.02 | 37 | $0 (2024) |
| SK Life Science, Inc. | $877.43 | 35 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $824.10 | 73 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $724.92 | 39 | $0 (2024) |
| Lundbeck LLC | $611.15 | 23 | $0 (2024) |
| EMD Serono, Inc. | $503.18 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $481.96 | 23 | $0 (2024) |
| PFIZER INC. | $424.74 | 24 | $0 (2024) |
| ARGENX US, INC. | $402.68 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,659 | 192 | ABBVIE INC. ($507.62) |
| 2023 | $2,989 | 162 | ABBVIE INC. ($565.10) |
| 2022 | $2,279 | 127 | SK Life Science, Inc. ($227.62) |
| 2021 | $1,940 | 103 | AbbVie Inc. ($312.59) |
| 2020 | $336.95 | 18 | Sunovion Pharmaceuticals Inc. ($49.96) |
| 2019 | $587.67 | 28 | ACADIA Pharmaceuticals Inc ($192.34) |
| 2018 | $54.39 | 3 | Sunovion Pharmaceuticals Inc. ($20.18) |
| 2017 | $311.38 | 23 | Depomed, Inc. ($45.13) |
All Payment Transactions
656 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.16 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $35.23 | General |
| Category: Neurology | ||||||
| 12/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.64 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.15 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Central Nervous System | ||||||
| 11/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: Central Nervous System | ||||||
| 11/14/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Neurology | ||||||
| 11/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Neuroscience | ||||||
| 10/24/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Neurology | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: Central Nervous System | ||||||
| 10/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.15 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 664 | 847 | $206,837 | $73,583 |
| 2022 | 14 | 644 | 827 | $199,264 | $68,509 |
| 2021 | 14 | 636 | 799 | $176,206 | $63,636 |
| 2020 | 11 | 630 | 688 | $135,261 | $42,163 |
Total Patients
2,574
Total Services
3,161
Medicare Billing
$247,892
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 332 | $83,332 | $28,913 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 156 | $27,612 | $9,176 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 52 | $18,252 | $6,309 | 34.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 58 | $14,790 | $5,708 | 38.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 46 | 80 | $15,360 | $5,661 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $11,772 | $4,489 | 38.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 12 | 12 | $9,072 | $3,342 | 36.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $6,896 | $2,522 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 40 | $6,200 | $2,396 | 38.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 17 | 17 | $5,865 | $2,219 | 37.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 12 | 12 | $3,168 | $1,103 | 34.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 25 | 25 | $2,725 | $1,058 | 38.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $1,793 | $689.04 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 203 | 300 | $75,600 | $25,299 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 57 | $20,235 | $7,703 | 38.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 60 | 102 | $20,500 | $7,357 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 119 | $21,301 | $6,035 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $15,660 | $5,712 | 36.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 29 | 31 | $8,463 | $2,807 | 33.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 35 | 37 | $7,215 | $2,803 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $8,225 | $2,713 | 33.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 12 | 12 | $5,160 | $1,803 | 34.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 30 | $4,140 | $1,616 | 39.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 36 | 37 | $4,144 | $1,612 | 38.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $3,419 | $1,330 | 38.9% |
About Dr. Khaled Kamel, MD
Dr. Khaled Kamel, MD is a Neurology healthcare provider based in Aiken, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720017015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khaled Kamel, MD has received a total of $12,157 in payments from pharmaceutical and medical device companies, with $3,659 received in 2024. These payments were reported across 656 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($12,036).
As a Medicare-enrolled provider, Kamel has provided services to 2,574 Medicare beneficiaries, totaling 3,161 services with total Medicare billing of $247,892. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Aiken, SC
- Active Since 07/01/2006
- Last Updated 01/22/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1720017015
Products in Payments
- NUPLAZID (Drug) $902.02
- INGREZZA (Drug) $649.66
- VYEPTI (Biological) $580.19
- UBRELVY (Drug) $566.44
- NURTEC ODT (Drug) $514.56
- BOTOX (Biological) $483.10
- AJOVY (Biological) $404.73
- KESIMPTA (Drug) $335.62
- DUOPA (Drug) $312.58
- QULIPTA (Drug) $286.79
- Ponvory (Drug) $245.39
- EMGALITY (Drug) $234.11
- VYVGART HYTRULO (Drug) $232.34
- Austedo XR (Drug) $213.51
- Fintepla (Drug) $213.22
- Aimovig (Biological) $204.50
- Fycompa (Drug) $186.67
- AUSTEDO (Drug) $178.36
- ULTOMIRIS (Biological) $175.28
- ZTLido (Drug) $174.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Aiken
Dr. Jose Cardenas, M.d, M.D
Neurology — Payments: $250,328
Neurology $250,328
Misbba Khan, Md, MD
Neurology — Payments: $9,930
Neurology $9,930
Michelle Lyon, M.d, M.D
Neurology — Payments: $876.49
Neurology $876.49
Anubha Jati, M.d, M.D
Neurology — Payments: $719.57
Neurology $719.57
Richard Eisenberg, Md, MD
Neurology — Payments: $57.47
Neurology $57.47